Leadership

Board of Directors
Executive Committee
Finance Committee
Governance Committee
NCCN Foundation Board of Directors
Management Team

NCCN Board of Directors

The NCCN Board of Directors is comprised of two representatives from each NCCN Member Institution who share in NCCN's mission to improve and facilitate quality, effective, equitable, and accessible cancer care so all patients can live better lives.

John W. Sweetenham, MD, FASCO, FRCP, FACP / Chair
UT Southwestern Simmons Comprehensive Cancer Center
Matt Kalaycio, MD / Vice-Chair
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Patrick J. O'Brien, MBA / Treasurer
Fox Chase Cancer Center
Maria M. Gonzalez, MPH / Secretary
Stanford Cancer Institute
Edwin P. Alyea III, MD
Duke Cancer Institute
Sachin M. Apte, MD, MBA, MS
Huntsman Cancer Institute at the University of Utah
James E. Bachman, MPA
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Al B. Benson III, MD, FASCO, FACP
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Richard Bold, MD, MBA
UC Davis Comprehensive Cancer Center
Rondeep Brar, MD
Stanford Cancer Institute
Laurel Bray-Hanin, MA
UCSF Helen Diller Family Comprehensive Cancer Center
Craig A. Bunnell, MD, MBA, MPH
Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
Rebecca L. Caires, MBA
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Joseph A. Califano III, MD
UC San Diego Moores Cancer Center
William E. Carson III, MD
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Peter Connor, MS
University of Wisconsin Carbone Cancer Center
Gena Cook
NCCN Foundation Board of Directors
Kenneth H. Cowan, MD, PhD
Fred & Pamela Buffett Cancer Center
Nancy E. Davidson, MD
Fred Hutchinson Cancer Center
Gina Dayton, MPA
UC Davis Comprehensive Cancer Center
Jordan M. DeMoss, MSHA
O'Neal Comprehensive Cancer Center at UAB
Timothy R. Donahue, MD
UCLA Jonsson Comprehensive Cancer Center
Timothy J. Eberlein, MD, FACS
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Stephen B. Edge, MD, FASCO, FACS
Roswell Park Comprehensive Cancer Center
David S. Ettinger, MD, FCCP, FACP
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Robin Famiglietti, PhD, MBA, FACHE
Duke Cancer Institute
Steven J. Frank, MD
The University of Texas MD Anderson Cancer Center
Laura W. Goff, MD, MSCI, MMHC
Vanderbilt-Ingram Cancer Center
Barbara A. Jagels, RN, MHA, CPHQ
UCLA Jonsson Comprehensive Cancer Center
Kris M. Kipp, MSN, RN
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Michael R. Kuettel, MD, PhD, MBA
Roswell Park Comprehensive Cancer Center
Ashley B. Lee
City of Hope National Medical Center
Kelvin P. Lee, MD
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Christopher H. Lieu, MD
University of Colorado Cancer Center
Christina J. Longnecker, BSN, MBA, JD, RN
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Cynthia McCollum, MBA
Memorial Sloan Kettering Cancer Center
Brittany McCreery, MD, MBA
Fred Hutchinson Cancer Center
Katie McGill, MSM
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Robert R. McWilliams, MD, MSc
Mayo Clinic Comprehensive Cancer Center
David B. Miller, MBA
Abramson Cancer Center at the University of Pennsylvania
Donald F. Milligan, MBA
Huntsman Cancer Institute at the University of Utah
Lisle M. Nabell, MD
O'Neal Comprehensive Cancer Center at UAB
Alberto S. Pappo, MD
St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
David G. Pfister, MD
Memorial Sloan Kettering Cancer Center
Lori C. Pickens, MHA
Yale Cancer Center/Smilow Cancer Hospital
Elizabeth R. Plimack, MD, MS
Fox Chase Cancer Center
Mitchell C. Posner, MD, FACS
The UChicago Medicine Comprehensive Cancer Center
Ravi Salgia, MD, PhD
City of Hope National Medical Center
Theresa Sberna, MPH
Vanderbilt-Ingram Cancer Center
Richard D. Schulick, MD, MBA, FACS
University of Colorado Cancer Center
David Shibata, MD, FASCRS, FACS
St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
Samuel M. Silver, MD, PhD, MACP
University of Michigan Rogel Cancer Center
Kyle F. Skiermont, PharmD
Fred & Pamela Buffett Cancer Center
David C. Smith, MD
University of Michigan Rogel Cancer Center
Elizabeth A. Souza, MHA
Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
Philippe E. Spiess, MD, MS, FACS, FRCS
Moffitt Cancer Center
Jolene Summer Bolster
Mayo Clinic Comprehensive Cancer Center
Kyle A. Taylor, MHSA, CPHQ
UT Southwestern Simmons Comprehensive Cancer Center
Theodoros Teknos, MD
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Yvette Tremonti, CPA, MBA
Moffitt Cancer Center
Alan P. Venook, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Robert H. Vonderheide, MD, DPhil
Abramson Cancer Center at the University of Pennsylvania
Lauren Wall, MS
The UChicago Medicine Comprehensive Cancer Center
Ronald S. Walters, MD, MBA, MHA, MS
The University of Texas MD Anderson Cancer Center
Lee G. Wilke, MD, FACS
University of Wisconsin Carbone Cancer Center

Executive Committee

John W. Sweetenham, MD, FACP, FRCP, FASCO / Chair
UT Southwestern Simmons Comprehensive Cancer Center
Nancy E. Davidson, MD
Fred Hutchinson Cancer Center
Maria M. Gonzalez, MPH
Stanford Cancer Institute
Barbara A. Jagels, RN, MHA, CPHQ
UCLA Jonsson Comprehensive Cancer Center
Matt Kalaycio, MD
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Christopher H. Lieu, MD
University of Colorado Cancer Center
Lisle M. Nabell, MD
O'Neal Comprehensive Cancer Center at UAB
Patrick J. O'Brien, MBA
Fox Chase Cancer Center
Yvette Tremonti, CPA, MBA
Moffitt Cancer Center
Ronald S. Walters, MD, MBA, MS, MHA
The University of Texas MD Anderson Cancer Center

Finance Committee

Patrick J. O'Brien, MBA / Chair
Fox Chase Cancer Center
James E. Bachman, MPA
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Kenneth H. Cowan, MD, PhD
Fred & Pamela Buffett Cancer Center
Robin Famiglietti, PhD, MBA, FACHE
Duke Cancer Institute
Katie McGill, MSM
Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Governance Committee

Matt Kalaycio, MD / Chair
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Timothy J. Eberlein, MD, FACS
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Laura W. Goff, MD, MSCI, MMHC
Vanderbilt-Ingram Cancer Center
Maria M. Gonzalez, MPH
Stanford Cancer Institute
Ashley B. Lee
City of Hope National Medical Center
David B. Miller, MBA
Abramson Cancer Center at the University of Pennsylvania
Patrick J. O'Brien, MBA
Fox Chase Cancer Center
John W. Sweetenham, MD, FACP, FRCP, FASCO
UT Southwestern Simmons Comprehensive Cancer Center

Foundation Board of Directors

Gena Cook / Chair
Blue Note Therapeutics
Heather J. Kopecky, PhD, MBA / Vice-Chair
Korn Ferry International
Patrick J. O'Brien, MBA / Treasurer
Fox Chase Cancer Center
Al B. Benson III, MD, FASCO, FACP
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Robert Carlson, MD
National Comprehensive Cancer Network
Patrick Delaney
NCCN Foundation
Angelique L. Richard, PhD, RN
Rush University Medical Center
Marc Samuels, JD, MPH
ADVI
Susan Stein, MPH
Agenus Inc.

NCCN Senior Management Team

Robert W. Carlson, MD, is the Chief Executive Officer (CEO) at the National Comprehensive Cancer Network (NCCN). He joined NCCN as CEO in January 2013 following an esteemed history of leadership positions within the organization including, most notably, Representative to the NCCN Board of Directors, Chair of the Breast Cancer Guidelines Panel, Member and Founding Chair of the Breast Cancer Risk Reduction Guidelines Panel, and Chair of the Survivorship Guidelines Panel.

Prior to his appointment as CEO at NCCN, Dr. Carlson served as Professor of Medicine in the Division of Oncology and Stanford Medical Informatics at Stanford University Medical Center, as well as Medical Director of inpatient oncology and hematology at Stanford Cancer Institute in Stanford, California.

Dr. Carlson is a graduate of Stanford University Medical School, and he completed his internship and junior residency in internal medicine at Barnes Hospital Group in St. Louis, Missouri before returning to Stanford University to complete his senior residency. He earned a Bachelor of Science with distinction from Stanford University, specializing in biological sciences. Dr. Carlson is board certified in Medical Oncology and Internal Medicine.

Dr. Carlson is a member of several medical societies, including American College of Physicians (ACP), American Association for Cancer Research (AACR), and the American Society of Clinical Oncology (ASCO). Dr. Carlson lectures extensively and has authored or co-authored more than 140 articles, abstracts, and book chapters, which have appeared in publications such as Journal of the National Cancer Institute, Journal of Clinical Oncology, and The Breast Journal. He has served as Associate Editor of Oncology and JNCCN — Journal of the National Comprehensive Cancer Network.

From 2001 to 2012, Dr. Carlson was selected by America’s Top Doctors; from 1994 to 2011, he was selected by Best Doctors in America; in 2008, he was presented with the National Physician of the Year Award for Clinical Excellence by Castle Connolly Medical, Ltd.; and in 2010, Dr. Carlson was given the Founding Collaborator Award by the Breast Health Global Initiative (BHGI).
Gary J. Weyhmuller, MBA, SPHR, is the Executive Vice President/Chief Operating Officer (EVP/COO) at the National Comprehensive Cancer Network (NCCN). Mr. Weyhmuller joined NCCN as EVP/COO in February 2014. Working closely with the CEO, he is responsible for providing leadership and management to NCCN Staff, helping to assure the development of new programs, as well as the continued efficient and effective operations of existing programs for NCCN Member Institutions and other constituencies.

Mr. Weyhmuller comes to NCCN with more than 35 years of experience at Fox Chase Cancer Center, most recently serving as Senior Vice President and Chief Operating Officer, responsible for leadership and oversight of the daily operations supporting all research, clinical, and operational activities for more than 2,400 employees. Prior to this role as SVP/COO, Mr. Weyhmuller held several other leadership roles within Fox Chase, including Vice President of Human Resources and Chief Administrative Officer.

Mr. Weyhmuller holds a Master of Business Administration from LaSalle University and a Bachelor of Science in education, political science, and minority studies from West Chester University. He also holds a certification as Senior Professional in Human Resources (SPHR) from Villanova University.

Outside of his professional career Mr. Weyhmuller demonstrates an active history of community service. Currently he is Vice Chair of the Board of Directors for American Heritage Federal Credit Union and a member of the Board of Directors for United Cerebral Palsy of Philadelphia and Vicinity, where he served as President of the Board from 2008 through 2011.

Mr. Weyhmuller is active in a number of professional organizations including the Healthcare Financial Management Association (HFMA), the American Hospital Association (AHA), the Association of American Cancer Institutes (AACI), and the Society for Human Resource Management (SHRM). He has been recognized for his leadership, both professionally and through his community service, including the Fox Chase Cancer Center Inspired Leadership Award, recognition for leadership and personal dedication on behalf of people with disabilities from United Cerebral Palsy of Philadelphia and Vicinity, and the Greater Northeast Philadelphia Chamber of Commerce Crystal Vision Award.
Wui-Jin Koh, MD, is the Senior Vice President/Chief Medical Officer at the National Comprehensive Cancer Network (NCCN). In this role, he helps oversee the flagship NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) program. In addition, he is responsible for medical leadership and oversight for NCCN’s continuing medical education program and JNCCN — Journal of the National Comprehensive Cancer Network, and represents the organization at clinical and scientific meetings. He is also actively involved in the NCCN Global initiatives.

Prior to joining NCCN in 2018, he served as Professor of Radiation Oncology at University of Washington and Medical Director for Radiation Oncology at Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Dr. Koh earned his medical degree at Loma Linda University School of Medicine. He conducted his post-graduate training at the University of Washington Medical Center, completing a residency in radiation oncology and a clinical fellowship in metabolic tumor imaging. He is board-certified in radiation oncology.

Dr. Koh’s research interests include combined chemo-radiation strategies, cancer management guidelines development, and the role of imaging in radiotherapy and cancer care. He specialized in the management of gynecologic and gastrointestinal tract tumors and the use of brachytherapy and intraoperative radiotherapy. He has received multiple Educator and National Top Doctors awards.

Dr. Koh is well-published and involved in numerous professional societies, including the Society of Gynecologic Oncology, the American Society of Clinical Oncology, the NRG-Oncology Clinical Trials Cooperative Group, the Western Association of Gynecologic Oncology, and the International Gynecologic Cancer Society. He also served as a member of the NCI Gynecologic Cancer Steering Committee from 2007-2015.
Crystal S. Denlinger, MD, FACP, is Senior Vice President, Chief Scientific Officer at the National Comprehensive Cancer Network (NCCN). She joined NCCN in April 2021. In her role, she helps steer strategic direction, oversees the NCCN Oncology Research Program (ORP), and provides input into NCCN’s clinical information program, including the NCCN Guidelines^® and continuing education activities.

Prior to joining NCCN, Dr. Denlinger held several leadership positions with Fox Chase Cancer Center—an NCCN Member Institution—including Chief, Gastrointestinal Medical Oncology; Deputy Director, Early Drug Development Phase 1 Program; Director, Survivorship Program; and Associate Professor, Department of Hematology/Oncology. After joining NCCN, she will continue to see patients at Fox Chase Cancer Center in a limited, volunteer capacity.

Dr. Denlinger has been involved with NCCN for many years, including serving as chair of the NCCN Guidelines Panel for Survivorship and serving on a number of panels, including the Esophageal/Gastric Cancers Panel, the JNCCN—Journal of the National Comprehensive Cancer Network Editorial Board, and on various abstract committees and ORP RFP committees, including chairing two committees. She was named an NCCN Young Investigator Awardee in 2012 and received the NCCN Rodger Winn Award in 2018 for exemplifying leadership, drive, and commitment in service to developing clinical practice guidelines.

She graduated from a combined BS/MD program at The College of New Jersey and Rutgers New Jersey Medical School, followed by an internal medicine residency with Mount Sinai Medical Center, and hematology/oncology fellowship at Fox Chase Cancer Center/Temple University Hospital. She has authored hundreds of clinical research articles and abstracts and received awards from organizations that include the American Society of Clinical Oncology (ASCO) Foundation and the American College of Physicians.
Eileen C. Boscia, CPA, MBA, is Vice President, Chief Financial Officer at the National Comprehensive Cancer Network (NCCN). Ms. Boscia joined NCCN in 2009 and is responsible for all aspects of financial accountability for NCCN and the NCCN Foundation including receivables, payables, financial reporting, internal controls, cash and investment management, and coordination of year-end audits for NCCN and NCCN Foundation. She is also responsible for risk management and compliance as well as review of legal, financial and other business issues concerning NCCN and the NCCN Foundation. She is responsible for providing financial and other analyses for strategic planning purposes.

Prior to working with NCCN, Ms. Boscia worked with a regional accounting firm performing audit, tax, accounting, and consulting services for small to mid-sized clients in a variety of industries including not-for-profits. She is a member of both the American Institution of Certified Public Accountants (AICPA) and the Pennsylvania Institute of Certified Public Accountants (PICPA).

Ms. Boscia has a Bachelor of Science in Accounting from the University of Delaware and a Master of Business Administration with a concentration in Management Information Systems from LaSalle University. She is also licensed as a Certified Public Accountant in Pennsylvania.
Kristina M. Gregory, RN, MSN, OCN, is Senior Vice President of Clinical Information Programs at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Gregory is responsible for production of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®). She also monitors and maintains tracking schedules representing the status of the NCCN Guidelines in the development process and web publication. Ms. Gregory also oversees production of NCCN Programs affiliated with the NCCN Guidelines^®, including the NCCN Compendium^® and NCCN Templates^®.

Prior to working with NCCN, Ms. Gregory served as a Health Management Program Coordinator at Independence Blue Cross in Philadelphia, PA and was also a staff nurse at Fox Chase Cancer Center. Ms. Gregory is an active member of the National and Bucks/Montgomery Counties Chapter of the Oncology Nursing Society (ONS), the American Society of Clinical Oncology (ASCO), and a volunteer for the Leukemia and Lymphoma Society.

Ms. Gregory has a master's degree in Public Health Nursing from La Salle University, and a B.S. in Nursing from the University of Pennsylvania. She is also a certified oncology nurse.
Linda Leach is Vice President, Administration & Human Resources at the National Comprehensive Cancer Network (NCCN). Ms.Leach joined NCCN in 2002 and is responsible for the administrative aspects of NCCN headquarters and the design, development, and administration of payroll and human resources programs and policies including recruitment, employee relations, performance management, compensation, and benefit plans.

Prior to joining NCCN, Linda worked in increasingly responsible positions in other health care-related organizations including senior leadership roles in administration and operations. She is a long-term member of the Society of Human Resource Management (SHRM) and the local SEPA SHRM.

Linda earned a Bachelor of Science degree at Neumann University with concentrations in Human Resource Development and Management Information Systems.
Jennifer Tredwell, MBA, is Vice President of Marketing & Communications at NCCN. In this role, Ms. Tredwell is responsible for the NCCN brand, website content, and strategic marketing plans of all programs and projects. She develops marketing and branding strategies for NCCN events, resources, publications, mobile apps, online learning, and research programs. She oversees the production of multi-channel digital and traditional marketing campaigns and is responsible for fundraising in the areas of sponsorships, exhibits, and advertising.

Prior to joining NCCN as full-time employee in 2005, Ms. Tredwell consulted for NCCN as well as a number of other health care organizations, including The Children’s Hospital of Philadelphia, Albert Einstein Healthcare Network, Moss Rehab, Beebe Medical Center, and The National Spine Network. She also worked for OneBeacon Insurance where she held a range of responsibilities in marketing and communications.

Ms. Tredwell received a Master of Business Administration from Temple University and a Bachelor of Arts from Syracuse University.
Beth Gaffney, MBA, is Vice President of U.S. and Global Business Development at NCCN. In this role, Ms. Gaffney oversees both U.S. and global business activities and the development of the NCCN brand worldwide. She helps ensure the influence of NCCN content and the ongoing collaboration and support of all stakeholders. She leads multiple functional areas across the organization, including business development (U.S. and global), business insights, commercial licensing, health information technology collaborations, and payer and employer outreach. She also works closely with NCCN’s marketing and communications department and oncology policy program.

Prior to joining NCCN, Ms. Gaffney led strategic business development for risk management and patient support services for United BioSource LLC. She also previously held positions with Johnson & Johnson’s McNeil Consumer Healthcare division and Men’s Health Magazine.

Ms. Gaffney received a Master of Business Administration from The Wharton School of the University of Pennsylvania and a Bachelor of Arts in International Relations from St. Joseph’s University.